AstraZeneca (AZN) Announces EU Approval of Imfinzi for Early Gastric/Gastroesophageal Cancers.
Share this article
Corporate
Score 75
Bullish
AstraZeneca (AZN) Announces EU Approval of Imfinzi for Early Gastric/Gastroesophageal Cancers
Mar 25, 2026 17:02 UTC
AZN, XLV, IWB
Short term
Related Articles
Score 85
Bullish
Merck to Buy Terns for $6.7B to Grow in Blood Cancers
Mar 25, 19:01
Score 65
Energy Uncertainty Delaying Some Deals: M&A Lawyer Spottswood
Mar 25, 18:58
Score 72
Bearish
Dolce & Gabbana Gears Up for Lender Talks as Debt Pressure Rises
Mar 25, 18:43
Score 65
Bullish
Chewy Posts Best Day in Two Years Amid Strong Pet Care Demand Despite Cost Concerns
Mar 25, 18:09
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.